Pipelle vs the Curved Aspirator Device
Recruiting now · Phase 4
Conditions studied: Endometrial Biopsy
In brief
The primary aim of this study is to rigorously compare the efficacy of two commonly used endometrial sampling devices, the Pipelle and the Miltex, these devices are standard of care at Maimonides. This primary objective is critical, as the ability to accurately reach the uterine cavity is fundamental to obtaining adequate samples for histopathological evaluation, which is crucial for diagnosing endometrial cancer and other uterine pathologies.
Key facts
- Study ID
- NCT07513493
- Run by
- Maimonides Medical Center
- People needed
- 124
- Starts
- 2026-01-02
- Expected to finish
- 2028-03-31
- Last updated by the study team
- 2026-04-07
Who can join
Age: 18 and older, up to 95. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Patients <18- 45 years with risk factors for endometrial cancer requiring endometrial biopsy.
- Patients ≥ 45 -95 years with abnormal uterine bleeding.
- Postmenopausal patients with bleeding or suspected endometrial pathology
You may not qualify if…
- Any patient who does not meet the inclusion criteria.
- Patients with contraindications to endometrial biopsy, including:
- Pregnancy
- Acute pelvic inflammatory disease
- Acute cervical infection
- Acute vaginal infection
- Cervical cancer
- Lack of patient consent
Where it is running
- Maimonides Medical Center — Brooklyn, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.